At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,036 enrolled
Drug / intervention
Vancomycin antibiotic powderdrug
Likely dose
Vancomycin antibiotic powder 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (Vancomycin Study)
In Brief
A Phase 3 clinical trial evaluating Vancomycin antibiotic powder for Post Operative Surgical Site Infection. Completed, enrolled 1,036 participants across 1 site.
Detailed Summary
The Vancomycin Study is a multi-center, prospective randomized controlled trial that will compare the proportion of deep surgical site infections within 6 months in patients treated with local Vancomycin powder compared to those treated without local Vancomycin powder at the time of fracture fixation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Operative Surgical Site Infection
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 2014
Enrollment StartOct 2014
Primary CompletionJun 2018
Study CompletionNov 2019
TodayJul 2026
First PostedAug 28, 2014
Enrollment StartOct 1, 2014
Primary CompletionJun 1, 2018
Study CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 11.8 years ago
Interventions
Vancomycin antibiotic powderdrug
At the time of fracture fixation 1000 mg of Vancomycin powder placed into the wound during wound closure.